| Jeff Pollard | 英国爱丁堡大学 | Cellular therapies to include CAR T cells |
| Arlene Sharpe | 美国哈佛大学 | Pd1-D在T细胞肿瘤治疗中的活化 |
| 曹雪涛 | 南开大学 | Long noncoding RNAs in the metabolic control of inflammation and immune disorders |
| 田志刚 | 中国科技大学 | Memory NK cells: why do they reside in the liver? |
| 韩卫东 | 中国人民解放军总医院 | Emerging predictors of the response to the blockade of immune checkpoints in cancer therapy |
| 黄波 | 中国医学科学院基础医学研究所 | new chemotherapeutic weapons on the battlefield of immune-related disease |
| Crystal L. Mackall | 美国斯坦福大学 | Programming CAR-T cells to kill cancer |
| Jeff Bluestone | 美国加利福尼亚大学 | The Immune Tolerance Network at 10 years: tolerance research at the bedside |
| Mark Smyth | 澳大利亚昆士兰大学 | Targeting immunosuppressive adenosine in cancer |
| Antoni Ribas | 美国加州大学洛杉矶分校 | Targeted agents and immunotherapies: optimizing outcomes in melanoma |
| 许琛琦 | 中国科学院上海生命学院 | Regulation of T cell signalling by membrane lipids |
| 邵峰 | 北京生命科学研究所 | The roles of macrophage autophagy in atherosclerosis |
| Luke O'Neill | 爱尔兰大学 | Mitochondria are the powerhouses of immunity |
| Erika Pearce | 德国菲乐堡（Freiburg）大学 | Emerging concepts of T cell metabolism as a target of immunotherapy |
| 魏海明 | 中国科技大学 | TH17 cells in human recurrent pregnancy loss and pre-eclampsia |
| Francesco Colucci | 法国巴斯德研究所 | Natural killer cell activation in mice and men: different triggers for similar weapons? |